DocMorris AG

DocMorris successfully completes the placement of CHF 200 million Convertible Bonds due 2029

DocMorris launches approx. CHF 200 million Convertible Bonds due 2029

DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market

DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card

DocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany

DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base